This study aims to determine whether preoperative radiomics based on contrast-enhanced computed tomography (CECT) imaging may help identify the PD-1 positive patients with HCC and further investigate its correlation with prognosis in patients using sorafenib after surgery. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.